CD8A and acute myeloid leukemia: Taken together, these findings suggest that Il1rl1 T-BsAb exert a dual inhibition of Il1rl1+ leukemic cells and tolerogenic Il1rl1+ immune cells including Tregs leading to expansion of cytotoxic CD8+ T cells resulting in synergistic killing of AML cells as well as LSCs.